Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
D000818:Animals; D002438:Cefoperazone; D002441:Cefsulodin; D002442:Ceftazidime; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D009070:Moxalactam; D011014:Pneumonia / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D013982:Ticarcillin / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use
D002511:Cephalosporins; D002513:Cephamycins; D002438:Cefoperazone; D002442:Ceftazidime; D013982:Ticarcillin; D002441:Cefsulodin; D009070:Moxalactam; D014031:Tobramycin